US Broker Ratings

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 213% Potential Upside in the Medical Devices Sector

Outset Medical, Inc. (NASDAQ: OM), a pioneering company in the healthcare sector, specifically within the medical devices industry, presents a fascinating case for investors with a notable potential upside of..

CytomX Therapeutics (CTMX) Stock Analysis: A Potential 165% Upside in the Biotech Arena

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is drawing significant attention in the biotechnology sector, as its potential upside looms large at 165.15%. For investors looking to delve into the healthcare market,..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a 255% Potential Upside

Arcturus Therapeutics Holdings (NASDAQ: ARCT), a biotechnology firm specializing in mRNA medicines, presents a unique investment opportunity with a staggering potential upside of 255.73%. Despite its current share price of..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: A Biotech Gem with 174% Potential Upside

For investors eyeing a promising opportunity in the healthcare sector, Fulcrum Therapeutics, Inc. (NASDAQ: FULC) stands out as a compelling option. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is..

Alpha Teknova, Inc. (TKNO) Stock Analysis: A 224.91% Upside Potential in the Healthcare Sector

Alpha Teknova, Inc. (NASDAQ: TKNO), a key player in the healthcare sector, is drawing significant attention from investors due to its potential upside of 224.91%. Specializing in the production of..

TruBridge, Inc. (TBRG) Stock Analysis: Exploring a 50% Potential Upside in the Health Information Services Sector

For investors keen on the healthcare sector, TruBridge, Inc. (NASDAQ: TBRG) presents an intriguing opportunity with a significant potential upside of 50.11%. Operating within the Health Information Services industry, TruBridge..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring a Potential 101% Upside in the Biotech Space

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a compelling player in the biotechnology sector, piquing interest with its robust potential upside of 101.26%. This San Francisco-based company is dedicated to developing..

Evolent Health, Inc (EVH)

⚠️ No article content returned.

..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: 45% Upside Potential Amid Strong Buy Ratings

Individual investors looking to navigate the volatile waters of the biotechnology sector may find Viridian Therapeutics, Inc. (NASDAQ: VRDN) an intriguing opportunity, particularly with its significant upside potential of over..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Healthcare Innovator with 40% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA) is capturing investor attention with a compelling growth narrative in the healthcare sector. Specializing in medical devices for breast aesthetic and reconstructive surgeries, this..

Harrow, Inc. (HROW) Stock Analysis: Eye-Catching 99% Potential Upside for Investors

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors with its impressive potential upside of nearly 99.44%, according to analyst ratings. As a key player in the healthcare sector,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring a 12.97% Potential Upside in the Healthcare Sector

The Pennant Group, Inc. (NASDAQ: PNTG) has emerged as a noteworthy player in the healthcare sector, particularly within medical care facilities. With a market capitalization of $1.16 billion, this dynamic..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: Exploring a 27.81% Potential Upside

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands as a compelling entity in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $976.15 million,..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 91.90% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is catching the attention of investors with its impressive potential upside of 91.90%. As a healthcare player in the biotechnology industry, this biopharmaceutical company is..

GRAIL, Inc. (GRAL) Stock Analysis: Is the 92% Potential Upside Worth the Risk?

GRAIL, Inc. (GRAL), a prominent player in the healthcare sector, specifically in diagnostics and research, has been capturing the attention of investors, largely due to its groundbreaking multi-cancer early detection..

Artivion, Inc. (AORT) Stock Analysis: Robust Revenue Growth and 37.51% Upside Potential

Investors seeking opportunities in the healthcare sector may find Artivion, Inc. (NYSE: AORT) an intriguing prospect. Specializing in medical devices, this U.S.-based company has demonstrated strong revenue growth, coupled with..

Wave Life Sciences Ltd. (WVE) Stock Analysis: 174% Potential Upside Sparks Investor Interest

Wave Life Sciences Ltd. (WVE) is capturing the attention of investors with its substantial potential upside of 174.48%, as indicated by the average target price of $34.06. This clinical-stage biotechnology..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 170% Potential Upside in the Biotech Sector

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology space, is turning heads with an impressive potential upside of 170.76%. With a current stock price of $2.77 and an..

Astrana Health Inc. (ASTH) Stock Analysis: 46% Potential Upside Beckons Investors

Astrana Health Inc. (NASDAQ: ASTH) is emerging as a notable player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.37 billion, Astrana..

Beam Therapeutics Inc. (BEAM) Stock Analysis: An Investor’s Guide to Potential 95.89% Upside

Beam Therapeutics Inc. (NASDAQ: BEAM) is a compelling prospect for investors keen on the biotechnology sector, particularly those interested in innovative genetic medicines. With a market capitalization of $2.6 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds